In fields where there aren't too many adversarial players (i'm talking about big industrial companies) like math or compsci things are kind of ok already. Its in biology and medicine where it's the worst. It's obviously because their fields are much more penetrated by the industry and more generally by economical goals. At some point you gotta be blind not to see that the ones dragging us behind (or more generally holding levers) are the guys with the big bucks.